Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir.
Nozomu HanaokaMasatoshi HazamaKoji FukushimaTsuguto FujimotoPublished in: Microbiology spectrum (2022)
Human mastadenovirus (HAdV), a linear double-stranded DNA (dsDNA) virus, is the causal agent of several diseases, including pharyngoconjunctival fever, epidemic keratoconjunctivitis, and hemorrhagic cystitis, in immunocompromised individuals. There are more than 100 reported types of adenoviruses, but the pathogenicity of many HAdVs remains unknown. Brincidofovir (BCV) is a hexadecyloxypropyl lipid conjugate of cidofovir (CDV) that is active against dsDNA viruses. Clinical effectiveness of BCV against certain HAdV species has been reported; however, its activity against novel HAdV types remains unknown. We investigated the half-maximal inhibitory concentration (IC 50 ) values of BCV for novel HAdV types and found that the epidemic keratoconjunctivitis-associated HAdV-D54 prevalent in the Asian region was the most susceptible. The mean overall IC 50 value of BCV was lower than that of CDV, indicating that BCV is effective against HAdVs, including the novel types. IMPORTANCE We investigated the IC 50 values of BCV for novel HAdV types and found that the epidemic keratoconjunctivitis-associated HAdV-D54 prevalent in the Asian region was the most susceptible. In addition, the mean overall IC 50 value of BCV was lower than that of CDV, indicating that BCV is effective against HAdVs.
Keyphrases
- endothelial cells
- randomized controlled trial
- induced pluripotent stem cells
- systematic review
- blood pressure
- intensive care unit
- pluripotent stem cells
- circulating tumor
- single molecule
- heart rate
- high resolution
- cancer therapy
- pseudomonas aeruginosa
- cell free
- body composition
- drug delivery
- biofilm formation
- nucleic acid
- candida albicans